{
"NDC": {
"NDCCode": "72205-204-60",
"PackageDescription": "60 CAPSULE in 1 BOTTLE (72205-204-60) ",
"NDC11Code": "72205-0204-60",
"ProductNDC": "72205-204",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Dabigatran",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Dabigatran Etexilate",
"DosageFormName": "CAPSULE",
"RouteName": "ORAL",
"StartMarketingDate": "20240522",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA213879",
"LabelerName": "Novadoz Pharmaceuticals LLC",
"SubstanceName": "DABIGATRAN ETEXILATE MESYLATE",
"StrengthNumber": "150",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Direct Thrombin Inhibitor [EPC], Thrombin Inhibitors [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2024-10-22",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20240524",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}